BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6891272)

  • 1. [Neuropharmacological properties of piracetam derivatives].
    Ostrovskaia RU; Molodavkin GM; Trofimov SS; Popova RIa; Gudasheva TA
    Biull Eksp Biol Med; 1982 Dec; 94(12):62-5. PubMed ID: 6891272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nootropic properties of gamma-aminobutyric acid derivatives].
    Ostrovskaia RU; Trofimov SS
    Biull Eksp Biol Med; 1984 Feb; 97(2):170-2. PubMed ID: 6538101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of piracetam and of standardized ginseng extract on the electroconvulsive shock-induced memory disturbances in "step-down" passive avoidance.
    Lasarova MB; Mosharrof AH; Petkov VD; Markovska VL; Petkov VV
    Acta Physiol Pharmacol Bulg; 1987; 13(2):11-7. PubMed ID: 3673597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative influence of nootropic preparations on the emetic effect of morphine].
    Naumova VI; Krylova IN; Drozd IuV; Polev PV; Bashnin IuI
    Biull Eksp Biol Med; 1989 Jun; 107(6):711-3. PubMed ID: 2790169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dissociation of the anti-amnesic and antihypoxic effects of nootropic and antihypoxic preparations].
    Voronina TA; Garibova TL; Khromova IV; Tilekeeva UM
    Farmakol Toksikol; 1987; 50(3):21-4. PubMed ID: 3609269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study of the nootropic properties of piracetam and oxiracetam].
    Krylova IN; Antonova LV; KamenskiÄ­ AA; Iasnetsov VV
    Farmakol Toksikol; 1991; 54(1):14-6. PubMed ID: 1860490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of piracetam on the neuronal activity of the neocortex and on behavior in rabbits during learning].
    Shul'gina GI; Okhotnikov NV; Ryzhov SO
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(3):460-6. PubMed ID: 3188641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The nootropic and anxiolytic properties of different doses of piracetam].
    Voronina TA; Molodavkin GM; Borlikova GG; Ostrovskaia RU; Tushmalova NA; Naznamov GG
    Eksp Klin Farmakol; 2000; 63(2):9-11. PubMed ID: 10834086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the pharmacological action of piracetam].
    MashkovskiÄ­ MD; Roshchina LF; Polezhaeva AI
    Farmakol Toksikol; 1977; 40(6):676-83. PubMed ID: 598489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Piracetam correction of deficient GABA-ergic inhibition due to early postnatal exposure to cycloheximide].
    Burov IuV; Ostrovskaia RU; Smol'nikova NM; Trofimov SS; Molodavkin GM
    Biull Eksp Biol Med; 1986 Apr; 101(4):447-9. PubMed ID: 3008881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative neurophysiological study of the nootropic drugs piracetam and centrophenoxine].
    Krapivin SV; Voronina TA
    Farmakol Toksikol; 1987; 50(6):17-20. PubMed ID: 3125062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [GABA-ergic cortical component in the action of piracetam and cetyl GABA].
    Ostrovskaia RU; Molodavkin GM; Kovalev GI
    Biull Eksp Biol Med; 1982 Apr; 93(4):62-4. PubMed ID: 7082805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological characteristics of a new phenyl analog of piracetam--4-phenylpiracetam].
    Bobkov IuG; Morozov IS; Glozman OM; Nerobkova LN; Zhmurenko LA
    Biull Eksp Biol Med; 1983 Apr; 95(4):50-3. PubMed ID: 6403074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The comparative characteristics of the effect of piracetam peptide analogs on the recovery of conditioned reflex activity in animals following damage to the frontal cortex and the electrophysiological characteristics of the brain integrative activity].
    Romanova GA; Gudasheva TA; Dobrynin VP; Ostrovskaia RU
    Eksp Klin Farmakol; 1992; 55(5):6-8. PubMed ID: 1305458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of piracetam and gamma-aminobutyric acid on defensive conditioned reflexes in Xenopus laevis].
    Karulina OIu; Saakian SA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):166-7. PubMed ID: 6837151
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of piracetam during prolonged use in an experiment].
    Rakhmankulova IKh; Garibova TL; Voronin KE; Tilekeeva UM; Voronina TA
    Farmakol Toksikol; 1985; 48(4):42-6. PubMed ID: 4043362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antagonism of piracetam with proline in relation to mnestic effects].
    Ostrovskaia RU; Trofimov SS; Tsybina NM; Gudasheva TA; Skoldinov AP
    Biull Eksp Biol Med; 1985 Mar; 99(3):311-4. PubMed ID: 3838687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piracetam and brain excitability. An electrophysiological study in cats.
    Dimov S; Moyanova S; Nikolov R; Nikolova M
    Methods Find Exp Clin Pharmacol; 1984 Feb; 6(2):83-9. PubMed ID: 6717174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity of the action of piracetam, encephabol and Cleregil on the transcallosal evoked potential].
    Voronina TA; Krapivin SV; Nerobkova LN
    Biull Eksp Biol Med; 1986 Mar; 101(3):320-2. PubMed ID: 3955218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.